Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
Notified -
Globe Newswire13-01-2025, 13:00
Constellation Brands Announces Revised Date to Report Third Quarter Fiscal 2025 Financial Results; Host Conference Call January 10, 2025 3-01-2025, 04:30